215 related articles for article (PubMed ID: 9534954)
21. Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
Yokozaki S; Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
J Med Virol; 2011 Oct; 83(10):1727-32. PubMed ID: 21837788
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
Fukuma T; Enomoto N; Marumo F; Sato C
Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
[TBL] [Abstract][Full Text] [Related]
23. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209-2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin.
Yen YH; Hung CH; Hu TH; Chen CH; Wu CM; Wang JH; Lu SN; Lee CM
Aliment Pharmacol Ther; 2008 Jan; 27(1):72-9. PubMed ID: 17973647
[TBL] [Abstract][Full Text] [Related]
25. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.
Duverlie G; Khorsi H; Castelain S; Jaillon O; Izopet J; Lunel F; Eb F; Penin F; Wychowski C
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1373-81. PubMed ID: 9634077
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.
Hung CH; Lee CM; Lu SN; Lee JF; Wang JH; Tung HD; Chen TM; Hu TH; Chen WJ; Changchien CS
J Viral Hepat; 2003 Mar; 10(2):87-94. PubMed ID: 12614464
[TBL] [Abstract][Full Text] [Related]
27. The NS5a gene of hepatitis C virus in patients treated with interferon-alpha.
McKechnie VM; Mills PR; McCruden EA
J Med Virol; 2000 Apr; 60(4):367-78. PubMed ID: 10686018
[TBL] [Abstract][Full Text] [Related]
28. Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?
Macquillan GC; Niu X; Speers D; English S; Garas G; Harnett GB; Reed WD; Allan JE; Jeffrey GP
J Gastroenterol Hepatol; 2004 May; 19(5):551-7. PubMed ID: 15086599
[TBL] [Abstract][Full Text] [Related]
29. Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy.
El-Shamy A; Shoji I; Saito T; Watanabe H; Ide YH; Deng L; Kawata S; Hotta H
Microbiol Immunol; 2011 Jun; 55(6):418-26. PubMed ID: 21371092
[TBL] [Abstract][Full Text] [Related]
30. Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses.
Muñoz de Rueda P; Casado J; Patón R; Quintero D; Palacios A; Gila A; Quiles R; León J; Ruiz-Extremera A; Salmerón J
J Virol; 2008 Jul; 82(13):6644-53. PubMed ID: 18448540
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients.
Bokharaei-Salim F; Keyvani H; Salehi-Vaziri M; Sadeghi F; Monavari SH; Mehrnoush L; Alavian SM
Arch Virol; 2014 Nov; 159(11):2893-9. PubMed ID: 25139545
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.
Hofgärtner WT; Polyak SJ; Sullivan DG; Carithers RL; Gretch DR
J Med Virol; 1997 Oct; 53(2):118-26. PubMed ID: 9334922
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment.
Berg T; Mas Marques A; Höhne M; Wiedenmann B; Hopf U; Schreier E
Hepatology; 2000 Dec; 32(6):1386-95. PubMed ID: 11093746
[TBL] [Abstract][Full Text] [Related]
34. NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.
Bouzgarrou N; Hassen E; Mahfoudh W; Gabbouj S; Schvoerer E; Ben Yahia A; Ben Mami N; Triki H; Chouchane L
J Med Virol; 2009 Dec; 81(12):2021-8. PubMed ID: 19856481
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.
Sarrazin C; Herrmann E; Bruch K; Zeuzem S
J Virol; 2002 Nov; 76(21):11079-90. PubMed ID: 12368350
[TBL] [Abstract][Full Text] [Related]
36. Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy.
Nakamoto S; Imazeki F; Arai M; Yasui S; Nakamura M; Haga Y; Sasaki R; Kanda T; Shirasawa H; Yokosuka O
Int J Mol Sci; 2015 Sep; 16(9):21177-90. PubMed ID: 26370958
[TBL] [Abstract][Full Text] [Related]
37. Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a.
Lusida MI; Nagano-Fujii M; Nidom CA; Soetjipto ; Handajani R; Fujita T; Oka K; Hotta H
J Clin Microbiol; 2001 Nov; 39(11):3858-64. PubMed ID: 11682498
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: their relation to viral load, response to interferon, and the nonstructural region 5A.
Watanabe K; Yoshioka K; Yano M; Ishigami M; Ukai K; Ito H; Miyata F; Mizutani T; Goto H
J Med Virol; 2005 Apr; 75(4):504-12. PubMed ID: 15714488
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
[TBL] [Abstract][Full Text] [Related]
40. The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype 1b infection.
Aslan N; Bozdayi AM; Cetinkaya H; Sarioğlu M; Türkay C; Bozkaya H; Karayalçin S; Yurtaydin C; Uzunalimoğlu O
Turk J Gastroenterol; 2004 Mar; 15(1):21-6. PubMed ID: 15264117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
